U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus. Clearance is possible as soon as early next week, according to a person familiar ...
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
After a year-long sprint, COVID-19 vaccines are finally at hand
Less than a year after an unknown coronavirus that has claimed 1.4 million lives began spreading across the globe, a number of highly promising COVID-19 vaccines are on the cusp of release. Health authorities could give a green light for emergency use within weeks, which ...
The WHO defined an infodemic as an overabundance of information, both online and offline, including "deliberate attempts to disseminate wrong information."
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
U.S. plans first vaccinations in weeks, Operation Warp Speed chief says
Vaccinations against COVID-19 in the U.S. will "hopefully” start in less than three weeks, according to the head of the federal government’s program to accelerate a vaccine. "On the 11th or on the 12th of December, hopefully the first people will be immunized across the ...
Two companies say their vaccines are 95% effective. What does that mean?
You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that’s not how the math works.
U.S. biotech giant Pfizer and German partner BioNTech sought approval Friday to roll out their coronavirus vaccine early, a first step toward relief as surging infections prompt a return to shutdowns that traumatized nations and the global economy earlier this year. The world is looking ...
Japan health ministry to monitor health of early COVID-19 vaccine recipients
The purpose of the follow-up survey will be to collect information before the launch of COVID-19 vaccinations nationwide.
Can first vaccines bring herd immunity? Experts have doubts.
Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Poorer nations must wait for vaccine as West locks down supply
While richer nations plan their vaccination programs poorer and developing countries face hurdles that could deny billions the first proven protection against the coronavirus.
